PEDIATRIX MEDICAL GROUP INC (MD) Stock Institutional Trading Activity
PEDIATRIX MEDICAL GROUP INC (MD) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC, Lountzis Asset Management, Hancock Classic Value, Sequoia Financial Advisors, and First Eagle U.S. Value. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.
Explore more:
- PEDIATRIX MEDICAL GROUP INC (MD) stock institutional ownership
- PEDIATRIX MEDICAL GROUP INC (MD) stock insider trading activity
- Stock rankings
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q3 2018 | Hancock Classic Value | Buy | 954,322 | 3,254,122 | $151,837 |
| Q2 2018 | Hancock Classic Value | Buy | 41,088 | 2,299,800 | $99,535 |
| Q1 2018 | Hancock Classic Value | Buy | 1,296,682 | 2,258,712 | $125,652 |
| Q4 2017 | Hancock Classic Value | Buy | 962,030 | 962,030 | $51,411 |
| Q2 2016 | Renaissance Technologies LLC | Sell | -189,400 | 252,200 | $18,267 |
| Q1 2016 | Renaissance Technologies LLC | Buy | 70,600 | 441,600 | $28,536 |
| Q2 2015 | Renaissance Technologies LLC | Sell | -89,300 | 371,000 | $27,495 |
| Q1 2015 | Renaissance Technologies LLC | Buy | 107,000 | 460,300 | $33,376 |
| Q4 2014 | Sequoia Financial Advisors | Sell | -1,045 | 3,208 | $212 |
| Q4 2014 | Renaissance Technologies LLC | Sell | -46,500 | 353,300 | $23,357 |
| Q3 2014 | Sequoia Financial Advisors | Sell | -1,830 | 4,253 | $233 |
| Q3 2014 | Renaissance Technologies LLC | Buy | 370,100 | 399,800 | $21,917 |
| Q2 2014 | Sequoia Financial Advisors | Buy | 280 | 6,083 | $354 |
| Q2 2014 | Renaissance Technologies LLC | Buy | 24,700 | 29,700 | $1,727 |
| Q1 2014 | Renaissance Technologies LLC | Buy | 5,000 | 5,000 | $310 |
| Q1 2014 | Sequoia Financial Advisors | Buy | 643 | 5,803 | $360 |
| Q4 2013 | Sequoia Financial Advisors | Buy | 5,160 | 5,160 | $275 |
| Q4 2013 | First Eagle U.S. Value | Buy | 4,000 | 8,000 | $427 |
| Q2 2013 | First Eagle U.S. Value | Buy | 4,000 | 4,000 | $366 |
Frequently asked questions about MD activity
Which institutional owners are buying MD?
Institutional owners buying MD include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in MD activity?
"Buy" means an investor increased their reported position in MD compared to the prior reporting period. This reflects growing exposure to PEDIATRIX MEDICAL GROUP INC (MD) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in MD increasing?
Institutional interest in MD can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.